I was holding LBT when it got FDA approval and the SP spiked 5-fold in a few days - v exciting. Admittedly, it mainly due to hype as the company didn't have recurring sales income at the time (and still doesn't). GSS is different in that it already has sales revenue growing nicely and plenty of cash. It feels a less risky stock, but still with plenty of upside as molecular diagnostics is such a growing field and FDA approval is still ahead. I'm not sure what sort of time frame's involved, often a share price will rise in anticipation of approval. I get the impression its maybe 1-2 years.
- Forums
- ASX - By Stock
- Ann: Appendix 4D and Half Year Financial Statements
GSS
genetic signatures limited
Add to My Watchlist
2.63%
!
37.0¢

I was holding LBT when it got FDA approval and the SP spiked...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $84.04M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 37.0¢ | $7.661K | 20.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 29782 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 27800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 29782 | 0.365 |
2 | 3407 | 0.360 |
4 | 130509 | 0.350 |
1 | 1683 | 0.300 |
1 | 25000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 27800 | 1 |
0.390 | 20000 | 1 |
0.400 | 111918 | 2 |
0.420 | 40000 | 2 |
0.455 | 5000 | 1 |
Last trade - 11.49am 10/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |